Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norman L Block

Showing results (11-20 of 81) with videos related to

Pageof 9
Sort By:
The Prostate|March 17, 2010
Antagonists of growth hormone-releasing hormone inhibit the proliferation of human benign prostatic hyperplasia cellsAgnieszka Siejka, Andrew V Schally, Norman L Block, et al.
BJU International|February 16, 2010
Mechanisms of inhibition of human benign prostatic hyperplasia in vitro by the luteinizing hormone-releasing hormone antagonist cetrorelixAgnieszka Siejka, Andrew V Schally, Norman L Block, et al.
Cell Cycle (Georgetown, Tex.)|February 5, 2015
Potentiating effects of GHRH analogs on the response to chemotherapyAndrew V Schally, Roberto Perez, Norman L Block, et al.
Thescientificworldjournal|July 7, 2009
A rare case of renal gastrinomaDevendar Katkoori, Srinivas Samavedi, Merce Jorda, et al.
Communicative & Integrative Biology|April 22, 2011
GHRH and wound healingHippokratis Kiaris, Norman L Block, Athanasios G Papavassiliou, et al.
Oncotarget|July 5, 2014
Targeted cytotoxic analog of luteinizing hormone-releasing hormone (LHRH), AEZS-108 (AN-152), inhibits the growth of DU-145 human castration-resistant prostate cancer in vivo and in vitro through elevating p21 and ROS levelsPetra Popovics, Andrew V Schally, Luca Szalontay, et al.
Current Drug Delivery|November 2, 2010
Use of analogs of peptide hormones conjugated to cytotoxic radicals for chemotherapy targeted to receptors on tumorsAndrew V Schally, Jorg B Engel, Gunter Emons, et al.
Journal of Molecular Endocrinology|November 10, 2009
Activation of mitogen-activated protein kinases by a splice variant of GHRH receptorNektarios Barabutis, Agnieszka Siejka, Andrew V Schally, et al.
International Journal of Cancer|February 22, 2002
Inhibition of cell proliferation, invasion, tumor growth and metastasis by an oral non-antimicrobial tetracycline analog (COL-3) in a metastatic prostate cancer modelBal L Lokeshwar, Marie G Selzer, Bao-Qian Zhu, et al.
Oncotarget|September 4, 2012
Antagonists of growth hormone-releasing hormone suppress in vivo tumor growth and gene expression in triple negative breast cancersRoberto Perez, Andrew V Schally, Irving Vidaurre, et al.
Pageof 9

Showing results (11-20 of 81) with videos related to

Sort By:
Pageof 9
The Prostate|March 17, 2010
Antagonists of growth hormone-releasing hormone inhibit the proliferation of human benign prostatic hyperplasia cellsAgnieszka Siejka, Andrew V Schally, Norman L Block, et al.
BJU International|February 16, 2010
Mechanisms of inhibition of human benign prostatic hyperplasia in vitro by the luteinizing hormone-releasing hormone antagonist cetrorelixAgnieszka Siejka, Andrew V Schally, Norman L Block, et al.
Cell Cycle (Georgetown, Tex.)|February 5, 2015
Potentiating effects of GHRH analogs on the response to chemotherapyAndrew V Schally, Roberto Perez, Norman L Block, et al.
Thescientificworldjournal|July 7, 2009
A rare case of renal gastrinomaDevendar Katkoori, Srinivas Samavedi, Merce Jorda, et al.
Communicative & Integrative Biology|April 22, 2011
GHRH and wound healingHippokratis Kiaris, Norman L Block, Athanasios G Papavassiliou, et al.
Oncotarget|July 5, 2014
Targeted cytotoxic analog of luteinizing hormone-releasing hormone (LHRH), AEZS-108 (AN-152), inhibits the growth of DU-145 human castration-resistant prostate cancer in vivo and in vitro through elevating p21 and ROS levelsPetra Popovics, Andrew V Schally, Luca Szalontay, et al.
Current Drug Delivery|November 2, 2010
Use of analogs of peptide hormones conjugated to cytotoxic radicals for chemotherapy targeted to receptors on tumorsAndrew V Schally, Jorg B Engel, Gunter Emons, et al.
Journal of Molecular Endocrinology|November 10, 2009
Activation of mitogen-activated protein kinases by a splice variant of GHRH receptorNektarios Barabutis, Agnieszka Siejka, Andrew V Schally, et al.
International Journal of Cancer|February 22, 2002
Inhibition of cell proliferation, invasion, tumor growth and metastasis by an oral non-antimicrobial tetracycline analog (COL-3) in a metastatic prostate cancer modelBal L Lokeshwar, Marie G Selzer, Bao-Qian Zhu, et al.
Oncotarget|September 4, 2012
Antagonists of growth hormone-releasing hormone suppress in vivo tumor growth and gene expression in triple negative breast cancersRoberto Perez, Andrew V Schally, Irving Vidaurre, et al.
Pageof 9